ANTIBODY ENGINEERING AND PERSPECTIVES IN THERAPY

被引:7
作者
LEFRANC, G [1 ]
LEFRANC, MP [1 ]
机构
[1] UNIV MONTPELLIER 2, IMMUNOGENET MOLEC LAB,CNRS,URA 1191, PL E BATAILLON, F-34095 MONTPELLIER 5, FRANCE
关键词
chimeric antibody; genetic engineering; homologous recombination; immunoadhesin; immunoglobulin; immunotoxin;
D O I
10.1016/0300-9084(90)90046-J
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Techniques of genetic engineering, homologous recombination, and gene transfection make it feasible to produce antigen-binding molecules with widely varying structures. Novel proteins which possess the binding specificity of antibody associated with sequences such as an enzyme or toxin have potential use in immunoassays, in imaging, in immunotherapy. Antibody fusion proteins can also be used as a means to purify proteins or to study the function of surface protooncogenes. This paper reviews the recent data on the obtention and utilisation of the genetically engineered antibody molecules, as well as the approach which consists on the expression in vitro, in Escherichia coli, of a practically unlimited repertoire of Fab fragments and antibody sites. © 1990.
引用
收藏
页码:639 / 651
页数:13
相关论文
共 74 条
[1]   HOMOLOGOUS RECOMBINATION CAN RESTORE NORMAL IMMUNOGLOBULIN PRODUCTION IN A MUTANT HYBRIDOMA CELL-LINE [J].
BAKER, MD ;
PENNELL, N ;
BOSNOYAN, L ;
SHULMAN, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (17) :6432-6436
[2]   HOMOLOGOUS RECOMBINATION BETWEEN TRANSFERRED AND CHROMOSOMAL IMMUNOGLOBULIN-KAPPA GENES [J].
BAKER, MD ;
SHULMAN, MJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) :4041-4047
[3]   ESCHERICHIA-COLI SECRETION OF AN ACTIVE CHIMERIC ANTIBODY FRAGMENT [J].
BETTER, M ;
CHANG, CP ;
ROBINSON, RR ;
HORWITZ, AH .
SCIENCE, 1988, 240 (4855) :1041-1043
[4]   SINGLE-CHAIN ANTIGEN-BINDING PROTEINS [J].
BIRD, RE ;
HARDMAN, KD ;
JACOBSON, JW ;
JOHNSON, S ;
KAUFMAN, BM ;
LEE, SM ;
LEE, T ;
POPE, SH ;
RIORDAN, GS ;
WHITLOW, M .
SCIENCE, 1988, 242 (4877) :423-426
[5]   ASSEMBLY OF FUNCTIONAL ANTIBODIES FROM IMMUNOGLOBULIN HEAVY AND LIGHT-CHAINS SYNTHESIZED IN ESCHERICHIA-COLI [J].
BOSS, MA ;
KENTEN, JH ;
WOOD, CR ;
EMTAGE, JS .
NUCLEIC ACIDS RESEARCH, 1984, 12 (09) :3791-3806
[6]   PRODUCTION OF FUNCTIONAL CHIMAERIC MOUSE HUMAN-ANTIBODY [J].
BOULIANNE, GL ;
HOZUMI, N ;
SHULMAN, MJ .
NATURE, 1984, 312 (5995) :643-646
[7]  
BROWN BA, 1987, CANCER RES, V47, P3577
[8]   COMPARISON OF THE EFFECTOR FUNCTIONS OF HUMAN-IMMUNOGLOBULINS USING A MATCHED SET OF CHIMERIC ANTIBODIES [J].
BRUGGEMANN, M ;
WILLIAMS, GT ;
BINDON, CI ;
CLARK, MR ;
WALKER, MR ;
JEFFERIS, R ;
WALDMANN, H ;
NEUBERGER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1351-1361
[9]   DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].
CAPON, DJ ;
CHAMOW, SM ;
MORDENTI, J ;
MARSTERS, SA ;
GREGORY, T ;
MITSUYA, H ;
BYRN, RA ;
LUCAS, C ;
WURM, FM ;
GROOPMAN, JE ;
BRODER, S ;
SMITH, DH .
NATURE, 1989, 337 (6207) :525-531
[10]   A RECOMBINANT IMMUNOTOXIN CONSISTING OF 2 ANTIBODY VARIABLE DOMAINS FUSED TO PSEUDOMONAS EXOTOXIN [J].
CHAUDHARY, VK ;
QUEEN, C ;
JUNGHANS, RP ;
WALDMANN, TA ;
FITZGERALD, DJ ;
PASTAN, I .
NATURE, 1989, 339 (6223) :394-397